CellX Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2020

Location

Shanghai China

Primary Industry

Food

About

Established in 2020 and based in Beijing, China, CellX is a biotechnology company that focuses on the research and development of cell culture meat. It has a kiloliter-ton pilot plant for cell culture meat. Ziliang Yang, the CEO and founder of the company, used to serve as a management consultant at Boston Consulting Group (BCG). The company has over 40 R&D team members, who graduated from Tsinghua University, Stanford University, Tufts University, and other universities. In June 2023, CellX closed a series A+ funding. CellX's main business is the research, development, production, and sales of cultivated meat products based on three-dimensional (3D) bioprinting technologies. The company has established cells, culture medium, process development, and product lines technology platforms. Its cell culture meat products include chicken, cows, and pigs. The cells cultivated in meat have the features of animal fibrous, structured, and chunks. The company generates revenue by selling cell culture meat products.

Current Investors

Purple Orange Ventures, Agronomics Limited, Lever VC

Request a demo to show more

Primary Industry

Food

Sub Industries

Meat, Poultry & Seafood Products, Biotechnology, Agribusiness

Website

www.cellx.co

Verticals

3D Printing, Agtech, Manufacturing

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.